Industry reports
Editor highlights

Publication dates

data types

Progesterone Market and Forecasts, April 2014

You might be interested in: breast cancer, dairy farming, hospital, more »

1-10 of 72 reports for Progesterone

Progesterone Market Analysis in Jordan

  • Industry report
  • March 2012
  • 68 pages

... On female breast synthetic analogues of progesterone have been developed to make the hormone available orally first developed for use as contraceptive agent many of these compounds bind to receptors ...

Global Drug and Medication Sector

  • Industry report
  • June 2013
  • 30 pages

... Wac price $185.09(3) Side effect (1) bioidentical natural progesterone non-bioidentical progestins (mpa, neta, drosperinone) breast cancer more favorable profile (e3n-epic study) increased ...

U.S. Drug and Medication Industry

  • Industry report
  • June 2013
  • 30 pages

... Design combination of estradiol + progesterone rld = reference listed drug api = active pharmaceutical ingredient converted (api) from solid / crystalline to a new liquid drug form estrace (rld ...

Drug and Medication Sector Analysis in The United States

  • Industry report
  • May 2012
  • 69 pages
  • by Research Paper

... As creatinine clearance during the inulin infusion (broken line), and over 24 hours as endogenous creatinine clearance (dotted line). Gi adaptations Anatomic Growing uterus Hormonal progesterone ...

Dairy Products and Egg Sector in Bangladesh and The United States

  • Industry report
  • May 2012
  • 15 pages

... This provisional pdf corresponds to the article as it appeared upon acceptance. Fully formatted pdf and full text (html) versions will be made available soon. Milk progesterone enzyme ...

Drug and Medication Business Brief

  • Industry report
  • April 2012
  • 8 pages

... In general toxicity studies were related to its mechanism of action as a modulator of progesterone and glucocorticoid receptors, with antiprogesterone activity observed at exposures similar to therapeutic ...

U.S. Hormone Sector Brief

  • Industry report
  • January 2012
  • 27 pages

... Of progesterone that are commonly administered orally as acetate derivatives. They are used for synchronization of estrous, but have also been used as growth promoters in cattle. Although forbidden within the eu ...

Endocrine, Nutritional and Metabolic Diseases Sector Analysis (endocrine, nutritional and metabolic diseases, cardiovascular disease, dermatological condition) in The United States

  • Industry report
  • June 2012
  • 57 pages

... Relative to fsh by pituitary gland Lh stimulates ovarian thecal cells to produce excessive androgen Ineffective suppression of the lh pulse frequency by estradiol and progesterone Androgen excess ...

Diagnostics Industry Brief

  • Industry report
  • February 2012
  • 2 pages

... In the non-pregnant cow. A single sample taken around 24 days after service will accurately identify non-pregnant cows with around 95% accuracy if progesterone levels are low. However although a high ...

Breast Cancer Business Analysis (breast cancer, stroke, colorectal cancer)

  • Industry report
  • April 2013
  • 110 pages

... Of breast cancer is slightly increased with a postmenopausal hormone therapy regimen consisting largely of transdermal estradiol combined with progestins, but not when combined with progesterone. Int ...

» Purchase Premium Reports (From $ 125 - $ 4 795)

13 reports for Progesterone
Zhejiang Medicine Co., Ltd. (600216) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zhejiang Medicine Co., Ltd. (600216) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Zhejiang Medicine Co., Ltd. (Zhejiang Medicine) is a biopharmaceutical company. It develops, manufactures and markets high-quality biological drugs, pharmaceutical intermediates and bio-pesticides. ...

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.